News about Kenvue

The European Commission approved Kimberly-Clark's $40 billion (€35.7 billion) acquisition of Kenvue, the maker of Tylenol, after Kimberly-Clark offered to sell all its tampon and other feminine hygiene brands in the European Economic Area. The divested brands, Kotex (including the Lidie sub-brand), Camelia and Record, are to be bought by Turkey-based Dilek Gida Uretim, which the Commission also approved as a suitable buyer. The Commission had worried the deal would reduce competition in the tampon market, particularly in Czechia, Estonia and Slovakia. Separately, Kenvue's second-quarter adjusted profit was 31 cents per share, marginally below the 32-cent analyst average, as its adjusted gross margin fell to 60.2% from 60.9% amid inflation, tariffs and currency-related costs.